Shortwave Life Sciences (AQSE: PSY) £250K Raised, Biotech Meets Digital Assets

StockBox spoke to Shortwave Life Sciences co-founder Stephen Murphy and executive chairman Rolf Gerritsen following the company’s £250,000 fundraise. They discussed the company’s strategic expansion into digital asset management, upcoming news flow, and why now could be a compelling time for investors to take notice.


✅ Key Points:

  • Raised £250,000 at a 150% premium to the market
  • Launching a digital asset management strategy
  • Strengthened leadership team with key appointments
  • Focused on advancing IP and clinical-stage mental health therapies
  • Upcoming news flow on digital strategy and operational growth

The funds raised will be used to undertake a comprehensive business review, with the aim of establishing a strategic framework to:

·      Strengthen and grow the Company’s core operating business.

·      Establish a Digital Asset Treasury Management function to support the operational Company funding requirements.


Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned